Radiotherapy is a pivotal method for treating malignant tumors, and enhancing the
therapeutic gain ratio of radiotherapy through physical techniques is the direction of modern …

Highlights•Liver cancer, a global threat, ranks sixth in incidence and is the second-leading
cause of cancer fatalities.•Despite effective treatments, issues like affordability and …

Introduction: Proton beam therapy (PBT) is known to be an effective locoregional treatment
for hepatocellular carcinoma (HCC). However, few comparative studies in treatment-naïve …

Simple Summary Hepatocellular carcinoma (HCC) is one of the most prevalent and
devastating malignancies worldwide. An ongoing phase-II clinical trial assesses the efficacy …

Stereotactic body radiation therapy (SBRT) is a promising treatment option for patients with
hepatocellular carcinoma (HCC), the most common type of primary liver cancer. 1 This …

Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death
worldwide. Despite the advent of screening efforts and algorithms to stratify patients into …

Hepatocellular carcinoma (HCC) is the most common liver tumor, with a continually rising
incidence. The curative treatment for HCC is surgical resection or liver transplantation; …

The incidence of HCC has been steadily rising in the United States and much of the world
for over 2 decades.[1] Liver transplantation (LT) remains the optimal treatment strategy for …

Purpose To summarize the magnetic resonance imaging manifestations of hepatocellular
carcinoma (HCC) with and without progression after stereotactic body radiation therapy …

Purpose: We hypothesized that optimizing the utility of stereotactic body radiotherapy
(SBRT) based on the individual patient's probability for tumor control and risk of liver injury …